Tags: MDMAecstasyPTSD therapycare continuumcommunication
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK | ||
| 2 | Lawrence Hodge Jalopnik Car culture site. | ||
| 3 | Kristen Monaco MedPage Today | ||
| 4 | Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | ||
| 5 | Karissa Bell Engadget Senior editor @engadget. DMs open. San Francisco | ||
| 6 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | STAT+: Three MDMA therapy papers retracted over data integrity concerns - about 1 month ago FDA rejects MDMA as a psychedelic treatment for PTSD - about 1 month ago Psychedelic investment continues to ramp up - 7 months ago | |
| 7 | Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania | The FDA Just Rejected a Bid for MDMA to Treat PTSD - about 1 month ago | |
| 8 | Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York | MDMA therapy didn’t get FDA approval. Now what? - about 1 month ago How should we sell psychedelics? - 2 months ago | |
| 9 | Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. | Buying shady weight loss drugs online is a bad idea, in case you were wondering - about 2 months ago | |
| 10 | Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. | STAT+: Drug wholesaler owners indicted for alleged role in diverting Gilead and J&J HIV medicines - 3 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - 11 months ago |